TD Cowen Reiterates Buy Rating for Agilent Technologies (NYSE:A)

TD Cowen reiterated their buy rating on shares of Agilent Technologies (NYSE:A) in a research report sent to investors on Monday morning, Stock Target Advisor reports. They currently have a $153.00 target price on the medical research company’s stock.

Several other equities research analysts have also commented on the stock. Robert W. Baird cut their price target on shares of Agilent Technologies from $147.00 to $136.00 and set an outperform rating for the company in a report on Thursday, May 30th. JPMorgan Chase & Co. lowered their price objective on Agilent Technologies from $165.00 to $155.00 and set an overweight rating on the stock in a report on Thursday, May 30th. UBS Group reduced their target price on Agilent Technologies from $155.00 to $141.00 and set a neutral rating for the company in a report on Thursday, May 30th. Barclays lowered their price target on Agilent Technologies from $135.00 to $125.00 and set an underweight rating on the stock in a research note on Friday, May 31st. Finally, Bank of America increased their price objective on Agilent Technologies from $134.00 to $140.00 and gave the company a neutral rating in a research note on Tuesday, June 25th. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average price target of $138.06.

Agilent Technologies Stock Up 1.0 %

A opened at $142.86 on Monday. The company has a fifty day moving average of $133.55 and a two-hundred day moving average of $137.81. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.64 and a current ratio of 2.15. Agilent Technologies has a fifty-two week low of $96.80 and a fifty-two week high of $155.35. The stock has a market capitalization of $41.68 billion, a price-to-earnings ratio of 33.77, a PEG ratio of 4.74 and a beta of 1.05.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.03. The firm had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.58 billion. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. Agilent Technologies’s revenue for the quarter was down 8.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.27 EPS. On average, research analysts expect that Agilent Technologies will post 5.24 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd were given a $0.236 dividend. The ex-dividend date of this dividend was Tuesday, July 2nd. This represents a $0.94 annualized dividend and a yield of 0.66%. Agilent Technologies’s payout ratio is 22.22%.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction dated Friday, July 26th. The stock was sold at an average price of $140.00, for a total transaction of $274,120.00. Following the completion of the sale, the chief executive officer now directly owns 26,076 shares of the company’s stock, valued at approximately $3,650,640. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $140.00, for a total value of $274,120.00. Following the sale, the chief executive officer now owns 26,076 shares of the company’s stock, valued at $3,650,640. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Dominique Grau sold 15,000 shares of the firm’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $133.28, for a total value of $1,999,200.00. Following the transaction, the senior vice president now owns 49,486 shares of the company’s stock, valued at $6,595,494.08. The disclosure for this sale can be found here. Insiders have sold 18,916 shares of company stock worth $2,527,860 over the last quarter.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Crewe Advisors LLC grew its stake in Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Livelsberger Financial Advisory purchased a new stake in shares of Agilent Technologies during the fourth quarter worth approximately $26,000. MV Capital Management Inc. increased its stake in shares of Agilent Technologies by 120.7% during the fourth quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock worth $27,000 after buying an additional 105 shares during the period. VisionPoint Advisory Group LLC purchased a new position in Agilent Technologies in the fourth quarter worth approximately $29,000. Finally, Ridgewood Investments LLC purchased a new position in Agilent Technologies in the second quarter worth approximately $29,000.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.